Facebook

2017年1月5日 星期四

[醫如往常] Senior Clerkship Day 113, 115: Pathology: hematology

    Hematology 林醫師
    MDS; myelodysplastic syndrome
    Pancytopenia
    CD31 megaloblasts 
    Erythroid aplasia
    MPO<50%
    CD34 
    CD117 (membrane)
    tdt(nuclear)
    Ki-67

    要配合Peripheral bloodMPN周邊血球是多而成熟,MDScytopenia
    myeloproliferative neoplasms

    Diagnostic criteria for MDS/MPN with ring sideroblasts and thrombocytosis
    MDS/MPN diagnostic criteria
    • Anemia associated with erythroid lineage dysplasia with or without multilineage dysplasia, 15% ring sideroblasts,* <1% blasts in PB and <5% blasts in the BM
    • Persistent thrombocytosis with platelet count 450 × 109/L
    • Presence of a SF3B1 mutation or, in the absence of SF3B1 mutation, no history of recent cytotoxic or growth factor therapy that could explain the myelodysplastic/myeloproliferative features
    • No BCR-ABL1 fusion gene, no rearrangement of PDGFRAPDGFRB, or FGFR1; or PCM1-JAK2; no (3;3)(q21;q26), inv(3)(q21q26) or del(5q)
    • No preceding history of MPN, MDS (except MDS-RS), or other type of MDS/MPN
    • * At least 15% ring sideroblasts required even if SF3B1 mutation is detected.
    • † A diagnosis of MDS/MPN-RS-T is strongly supported by the presence of SF3B1 mutation together with a mutation in JAK2 V617F, CALR, or MPL genes.
    • ‡ In a case which otherwise fulfills the diagnostic criteria for MDS with isolated del(5q)-no or minimal absolute basophilia; basophils usually <2% of leukocytes.
    ------------
    PB and BM findings and cytogenetics of MDS
    Name
    Dysplastic lineages
    Cytopenias*
    Ring sideroblasts as % of marrow erythroid elements
    BM and PB blasts
    Cytogenetics by conventional karyotype analysis
    MDS with single lineage dysplasia (MDS-SLD)
    1
    1 or 2
    <15%/<5%
    BM <5%, PB <1%, no Auer rods
    Any, unless fulfills all criteria for MDS with isolated del(5q)
    MDS with multilineage dysplasia (MDS-MLD)
    2 or 3
    1-3
    <15%/<5%
    BM <5%, PB <1%, no Auer rods
    Any, unless fulfills all criteria for MDS with isolated del(5q)
    MDS with ring sideroblasts (MDS-RS)





    MDS-RS with single lineage dysplasia (MDS-RS-SLD)
    1
    1 or 2
    15%/5%
    BM <5%, PB <1%, no Auer rods
    Any, unless fulfills all criteria for MDS with isolated del(5q)
    MDS-RS with multilineage dysplasia (MDS-RS-MLD)
    2 or 3
    1-3
    15%/5%
    BM <5%, PB <1%, no Auer rods
    Any, unless fulfills all criteria for MDS with isolated del(5q)
    MDS with isolated del(5q)
    1-3
    1-2
    None or any
    BM <5%, PB <1%, no Auer rods
    del(5q) alone or with 1 additional abnormality except 7 or del(7q)
    MDS with excess blasts (MDS-EB)





    MDS-EB-1
    0-3
    1-3
    None or any
    BM 5%-9% or PB 2%-4%, no Auer rods
    Any
    MDS-EB-2
    0-3
    1-3
    None or any
    BM 10%-19% or PB 5%-19% or Auer rods
    Any
    MDS, unclassifiable (MDS-U)





    with 1% blood blasts
    1-3
    1-3
    None or any
    BM <5%, PB = 1%, no Auer rods
    Any
    with single lineage dysplasia and pancytopenia
    1
    3
    None or any
    BM <5%, PB <1%, no Auer rods
    Any
    based on defining cytogenetic abnormality
    0
    1-3
    <15%§
    BM <5%, PB <1%, no Auer rods
    MDS-defining    abnormality
    Refractory cytopenia of childhood
    1-3
    1-3
    None
    BM <5%, PB <2%
    Any
    • * Cytopenias defined as: hemoglobin, <10 g/dL; platelet count, <100 × 109/L; and absolute neutrophil count, <1.8 × 109/L. Rarely, MDS may present with mild anemia or thrombocytopenia above these levels. PB monocytes must be <1 × 109/L
    • † If SF3B1 mutation is present.
    • ‡ One percent PB blasts must be recorded on at least 2 separate occasions.
    • § Cases with 15% ring sideroblasts by definition have significant erythroid dysplasia, and are classified as MDS-RS-SLD.



    ------------
    Myeloma
    CD138 plasma cell
    CD56 +/-
    CD79a -
    ------------
    Megalokaryocytes: CD31

    ------------
    Desmoplastic small round cell tumor
    WT1 +
    CK -
    ------------
    Diffuse large B cell
    Intra vascular
    ------------
    尤醫師
    Paracortex: T cells
    Mantle zone: naïve B
    Germinal center: hyperpigmentation, class swich
    ------------
    Low grade B cell lymphoma: Congo red +
    Follicular type: BCL6, CD10 (normalneutrophil, stroma)
    Mantle zone: cyclinD1, CD5 (normalT-cell)
    Marginal zone: CD43
    CLL: CD5, CD23 (normalfollicular dendritic cells)
    SLL
    ------------
     Chronic lymphocytic leukemia in (Richter's) transformation
    出現平常B cell沒有的CD43
    Germinal center 喪失bcl-2
    ------------
    Clusters of CD123 positive PDC were observed in Kikuchi's disease
    Post. neck
    ------------
    Asia nose necrosis->NK/T cell lymphoma
    Angiocentric pattern
    CD3 (cyto)
    CD5 (-)
    ------------

沒有留言:

張貼留言

歡迎指教